# Cadence Design Systems Inc: financial statements, quarterly

CDNS · Nasdaq · CIK 813672 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cdns.md) · [Financials](/companies/cdns/financials.md) · [Filings](/companies/cdns/filings.md) · [Insiders](/companies/cdns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cdns/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [977](/filings/0000813672-24-000155.md) | [1,023](/filings/0000813672-24-000192.md) | [1,069 d](/filings/0000813672-26-000016.md) | [1,009](/filings/0000813672-25-000051.md) | [1,061](/filings/0000813672-25-000113.md) | [1,215](/filings/0000813672-25-000148.md) | [1,356 d](/filings/0000813672-26-000016.md) | [1,242](/filings/0000813672-26-000047.md) | [1,275](/filings/0000813672-25-000113.md) | [1,339](/filings/0000813672-25-000148.md) | [1,440 d](/filings/0000813672-26-000016.md) | [1,474](/filings/0000813672-26-000047.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [354](/filings/0000813672-24-000155.md) | [370](/filings/0000813672-24-000192.md) | not reported | [379](/filings/0000813672-25-000051.md) | [371](/filings/0000813672-25-000113.md) | [407](/filings/0000813672-25-000148.md) | not reported | [439](/filings/0000813672-26-000047.md) | [442](/filings/0000813672-25-000113.md) | [423](/filings/0000813672-25-000148.md) | not reported | [508](/filings/0000813672-26-000047.md) |
| Operating income | $m | [299](/filings/0000813672-24-000155.md) | [293](/filings/0000813672-24-000192.md) | [337 d](/filings/0000813672-26-000016.md) | [250](/filings/0000813672-25-000051.md) | [294](/filings/0000813672-25-000113.md) | [350](/filings/0000813672-25-000148.md) | [457 d](/filings/0000813672-26-000016.md) | [362](/filings/0000813672-26-000047.md) | [242](/filings/0000813672-25-000113.md) | [425](/filings/0000813672-25-000148.md) | [463 d](/filings/0000813672-26-000016.md) | [431](/filings/0000813672-26-000047.md) |
| Interest expense | $m | [8.9](/filings/0000813672-24-000155.md) | [9.1](/filings/0000813672-24-000192.md) | [9.0 d](/filings/0000813672-26-000016.md) | [8.7](/filings/0000813672-25-000051.md) | [12.9](/filings/0000813672-25-000113.md) | [24.5](/filings/0000813672-25-000148.md) | [29.9 d](/filings/0000813672-26-000016.md) | [29.1](/filings/0000813672-26-000047.md) | [28.9](/filings/0000813672-25-000113.md) | [29.0](/filings/0000813672-25-000148.md) | [29.4 d](/filings/0000813672-26-000016.md) | [31.6](/filings/0000813672-26-000047.md) |
| Income tax | $m | [77.3](/filings/0000813672-24-000155.md) | [45.6](/filings/0000813672-24-000192.md) | [38.2 d](/filings/0000813672-26-000016.md) | [62.4](/filings/0000813672-25-000051.md) | [86.2](/filings/0000813672-25-000113.md) | [95.3](/filings/0000813672-25-000148.md) | [96.4 d](/filings/0000813672-26-000016.md) | [82.1](/filings/0000813672-26-000047.md) | [121](/filings/0000813672-25-000113.md) | [106](/filings/0000813672-25-000148.md) | [105 d](/filings/0000813672-26-000016.md) | [92.4](/filings/0000813672-26-000047.md) |
| Net income | $m | [221](/filings/0000813672-24-000155.md) | [254](/filings/0000813672-24-000192.md) | [324 d](/filings/0000813672-26-000016.md) | [248](/filings/0000813672-25-000051.md) | [230](/filings/0000813672-25-000113.md) | [238](/filings/0000813672-25-000148.md) | [340 d](/filings/0000813672-26-000016.md) | [274](/filings/0000813672-26-000047.md) | [160](/filings/0000813672-25-000113.md) | [287](/filings/0000813672-25-000148.md) | [388 d](/filings/0000813672-26-000016.md) | [336](/filings/0000813672-26-000047.md) |
| Diluted EPS | $ per share | [0.81](/filings/0000813672-24-000155.md) | [0.93](/filings/0000813672-24-000192.md) | not reported | [0.91](/filings/0000813672-25-000051.md) | [0.84](/filings/0000813672-25-000113.md) | [0.87](/filings/0000813672-25-000148.md) | not reported | [1.00](/filings/0000813672-26-000047.md) | [0.59](/filings/0000813672-25-000113.md) | [1.05](/filings/0000813672-25-000148.md) | not reported | [1.23](/filings/0000813672-26-000047.md) |
| Basic EPS | $ per share | [0.82](/filings/0000813672-24-000155.md) | [0.94](/filings/0000813672-24-000192.md) | not reported | [0.92](/filings/0000813672-25-000051.md) | [0.85](/filings/0000813672-25-000113.md) | [0.87](/filings/0000813672-25-000148.md) | not reported | [1.01](/filings/0000813672-26-000047.md) | [0.59](/filings/0000813672-25-000113.md) | [1.06](/filings/0000813672-25-000148.md) | not reported | [1.23](/filings/0000813672-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0000813672-23-000041.md) | [1.0](/filings/0000813672-23-000068.md) | [1.0](/filings/0000813672-25-000024.md) | [1.0](/filings/0000813672-24-000092.md) | [1.1](/filings/0000813672-24-000155.md) | [2.8](/filings/0000813672-24-000192.md) | [2.6](/filings/0000813672-26-000016.md) | [2.8](/filings/0000813672-25-000051.md) | [2.8](/filings/0000813672-25-000113.md) | [2.8](/filings/0000813672-25-000148.md) | [3.0](/filings/0000813672-26-000047.md) | [1.4](/filings/0000813672-26-000047.md) |
| Current assets | $bn | [1.6](/filings/0000813672-23-000041.md) | [1.8](/filings/0000813672-23-000068.md) | [2.0](/filings/0000813672-25-000024.md) | [1.9](/filings/0000813672-24-000092.md) | [2.2](/filings/0000813672-24-000155.md) | [4.1](/filings/0000813672-24-000192.md) | [4.0](/filings/0000813672-26-000016.md) | [4.0](/filings/0000813672-25-000051.md) | [4.2](/filings/0000813672-25-000113.md) | [4.3](/filings/0000813672-25-000148.md) | [4.7](/filings/0000813672-26-000047.md) | [3.2](/filings/0000813672-26-000047.md) |
| Total assets | $bn | [5.2](/filings/0000813672-23-000041.md) | [5.4](/filings/0000813672-23-000068.md) | [5.7](/filings/0000813672-25-000024.md) | [5.7](/filings/0000813672-24-000092.md) | [7.2](/filings/0000813672-24-000155.md) | [9.2](/filings/0000813672-24-000192.md) | [9.0](/filings/0000813672-26-000016.md) | [9.0](/filings/0000813672-25-000051.md) | [9.5](/filings/0000813672-25-000113.md) | [9.6](/filings/0000813672-25-000148.md) | [10.2](/filings/0000813672-26-000047.md) | [12.1](/filings/0000813672-26-000047.md) |
| Current liabilities | $bn | [1.2](/filings/0000813672-23-000041.md) | [1.3](/filings/0000813672-23-000068.md) | [1.6](/filings/0000813672-25-000024.md) | [1.5](/filings/0000813672-24-000092.md) | [1.5](/filings/0000813672-24-000155.md) | [1.7](/filings/0000813672-24-000192.md) | [1.4](/filings/0000813672-26-000016.md) | [1.3](/filings/0000813672-25-000051.md) | [1.5](/filings/0000813672-25-000113.md) | [1.4](/filings/0000813672-25-000148.md) | [1.6](/filings/0000813672-26-000047.md) | [2.2](/filings/0000813672-26-000047.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.9](/filings/0000813672-24-000192.md) | [3.1](/filings/0000813672-24-000192.md) | [3.4](/filings/0000813672-26-000016.md) | [3.6](/filings/0000813672-25-000113.md) | [4.3](/filings/0000813672-25-000148.md) | [4.6](/filings/0000813672-25-000148.md) | [4.7](/filings/0000813672-26-000047.md) | [4.8](/filings/0000813672-26-000047.md) | [5.0](/filings/0000813672-25-000148.md) | [5.2](/filings/0000813672-25-000148.md) | [5.5](/filings/0000813672-26-000047.md) | [6.6](/filings/0000813672-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [414 d](/filings/0000813672-24-000155.md) | [396 d](/filings/0000813672-24-000192.md) | [272 d](/filings/0000813672-26-000016.md) | [253](/filings/0000813672-25-000051.md) | [156 d](/filings/0000813672-25-000113.md) | [410 d](/filings/0000813672-25-000148.md) | [441 d](/filings/0000813672-26-000016.md) | [487](/filings/0000813672-26-000047.md) | [378 d](/filings/0000813672-25-000113.md) | [311 d](/filings/0000813672-25-000148.md) | [553 d](/filings/0000813672-26-000016.md) | [356](/filings/0000813672-26-000047.md) |
| Capital expenditure | $m | [19.9 d](/filings/0000813672-24-000155.md) | [22.0 d](/filings/0000813672-24-000192.md) | [33.7 d](/filings/0000813672-26-000016.md) | [49.6](/filings/0000813672-25-000051.md) | [29.2 d](/filings/0000813672-25-000113.md) | [26.5 d](/filings/0000813672-25-000148.md) | [37.2 d](/filings/0000813672-26-000016.md) | [23.1](/filings/0000813672-26-000047.md) | [44.1 d](/filings/0000813672-25-000113.md) | [33.7 d](/filings/0000813672-25-000148.md) | [41.0 d](/filings/0000813672-26-000016.md) | [48.8](/filings/0000813672-26-000047.md) |
| Share repurchases | $m | [325 d](/filings/0000813672-24-000155.md) | [125 d](/filings/0000813672-24-000192.md) | [125 d](/filings/0000813672-26-000016.md) | [125](/filings/0000813672-25-000051.md) | [125 d](/filings/0000813672-25-000113.md) | [150 d](/filings/0000813672-25-000148.md) | [150 d](/filings/0000813672-26-000016.md) | [350](/filings/0000813672-26-000047.md) | [175 d](/filings/0000813672-25-000113.md) | [200 d](/filings/0000813672-25-000148.md) | [200 d](/filings/0000813672-26-000016.md) | [200](/filings/0000813672-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-07-02) | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [275](/filings/0000813672-23-000041.md) | [275](/filings/0000813672-23-000068.md) | [273](/filings/0000813672-24-000092.md) | [273](/filings/0000813672-24-000155.md) | [272](/filings/0000813672-24-000192.md) | [274](/filings/0000813672-25-000051.md) | [274](/filings/0000813672-25-000113.md) | [274](/filings/0000813672-25-000148.md) | [274](/filings/0000813672-26-000047.md) | [273](/filings/0000813672-25-000113.md) | [274](/filings/0000813672-25-000148.md) | [274](/filings/0000813672-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 275,816,000 at 2026-03-31, from the cover of the [10-Q filed 2026-05-01](/filings/0000813672-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.